AMGN logo

Amgen (AMGN) Free cash flow

annual FCF:

$10.39B+$3.04B(+41.24%)
December 31, 2024

Summary

  • As of today (April 16, 2025), AMGN annual free cash flow is $10.39 billion, with the most recent change of +$3.04 billion (+41.24%) on December 31, 2024.
  • During the last 3 years, AMGN annual FCF has risen by +$2.01 billion (+24.02%).
  • AMGN annual FCF is now -1.55% below its all-time high of $10.56 billion, reached on December 31, 2018.

Performance

AMGN Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMGNcash flow metrics

quarterly FCF:

$4.40B+$1.09B(+32.77%)
December 31, 2024

Summary

  • As of today (April 16, 2025), AMGN quarterly free cash flow is $4.40 billion, with the most recent change of +$1.09 billion (+32.77%) on December 31, 2024.
  • Over the past year, AMGN quarterly FCF has increased by +$4.11 billion (+1422.49%).
  • AMGN quarterly FCF is now at all-time high.

Performance

AMGN quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMGNcash flow metrics

TTM FCF:

$10.39B+$4.11B(+65.43%)
December 31, 2024

Summary

  • As of today (April 16, 2025), AMGN TTM free cash flow is $10.39 billion, with the most recent change of +$4.11 billion (+65.43%) on December 31, 2024.
  • Over the past year, AMGN TTM FCF has increased by +$3.04 billion (+41.24%).
  • AMGN TTM FCF is now -4.36% below its all-time high of $10.87 billion, reached on March 31, 2018.

Performance

AMGN TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMGNcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

AMGN Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+41.2%+1422.5%+41.2%
3 y3 years+24.0%+74.5%+24.0%
5 y5 years+21.8%+89.2%+18.2%

AMGN Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+41.2%at high+1422.5%at high+89.6%
5 y5-yearat high+41.2%at high+1422.5%at high+89.6%
alltimeall time-1.6%>+9999.0%at high+6127.4%-4.4%>+9999.0%

Amgen Free cash flow History

DateAnnualQuarterlyTTM
Dec 2024
$10.39B(+41.2%)
$4.40B(+32.8%)
$10.39B(+65.4%)
Sep 2024
-
$3.31B(+49.2%)
$6.28B(+14.6%)
Jun 2024
-
$2.22B(+383.9%)
$5.48B(-22.8%)
Mar 2024
-
$459.00M(+58.8%)
$7.10B(-3.5%)
Dec 2023
$7.36B(-16.2%)
$289.00M(-88.5%)
$7.36B(-21.5%)
Sep 2023
-
$2.51B(-34.5%)
$9.38B(-3.2%)
Jun 2023
-
$3.84B(+433.1%)
$9.69B(+28.6%)
Mar 2023
-
$720.00M(-68.8%)
$7.53B(-14.3%)
Dec 2022
$8.79B(+4.8%)
$2.31B(-18.1%)
$8.79B(-2.4%)
Sep 2022
-
$2.82B(+67.3%)
$9.00B(+7.7%)
Jun 2022
-
$1.68B(-14.7%)
$8.36B(-0.7%)
Mar 2022
-
$1.97B(-21.7%)
$8.42B(+0.4%)
Dec 2021
$8.38B(-15.2%)
$2.52B(+15.9%)
$8.38B(+6.9%)
Sep 2021
-
$2.18B(+24.6%)
$7.84B(-11.9%)
Jun 2021
-
$1.75B(-9.9%)
$8.90B(-9.5%)
Mar 2021
-
$1.94B(-2.1%)
$9.84B(-0.5%)
Dec 2020
$9.89B(+15.9%)
$1.98B(-38.8%)
$9.89B(-3.4%)
Sep 2020
-
$3.23B(+20.5%)
$10.23B(+0.3%)
Jun 2020
-
$2.68B(+34.7%)
$10.21B(+16.1%)
Mar 2020
-
$1.99B(-14.4%)
$8.79B(+3.1%)
Dec 2019
$8.53B(-19.2%)
$2.33B(-27.5%)
$8.53B(-7.0%)
Sep 2019
-
$3.21B(+152.5%)
$9.18B(+1.2%)
Jun 2019
-
$1.27B(-26.5%)
$9.07B(-6.6%)
Mar 2019
-
$1.73B(-41.8%)
$9.71B(-8.0%)
Dec 2018
$10.56B(+0.4%)
$2.97B(-4.3%)
$10.56B(+1.1%)
Sep 2018
-
$3.10B(+62.0%)
$10.45B(-1.8%)
Jun 2018
-
$1.92B(-25.5%)
$10.64B(-2.1%)
Mar 2018
-
$2.57B(-10.0%)
$10.87B(+3.4%)
Dec 2017
$10.51B(+9.3%)
$2.86B(-13.3%)
$10.51B(-0.1%)
Sep 2017
-
$3.30B(+53.9%)
$10.53B(+7.1%)
Jun 2017
-
$2.14B(-3.4%)
$9.82B(-2.5%)
Mar 2017
-
$2.22B(-22.8%)
$10.07B(+4.8%)
Dec 2016
$9.62B(+5.2%)
$2.87B(+10.8%)
$9.62B(+11.7%)
Sep 2016
-
$2.59B(+8.5%)
$8.61B(-2.4%)
Jun 2016
-
$2.39B(+35.9%)
$8.82B(-7.5%)
Mar 2016
-
$1.76B(-5.8%)
$9.53B(+4.3%)
Dec 2015
$9.14B(+14.9%)
$1.87B(-33.4%)
$9.14B(-6.5%)
Sep 2015
-
$2.80B(-9.6%)
$9.77B(+4.1%)
Jun 2015
-
$3.10B(+127.3%)
$9.39B(+12.5%)
Mar 2015
-
$1.36B(-45.5%)
$8.34B(+5.0%)
Dec 2014
$7.95B(+42.0%)
$2.50B(+3.4%)
$7.95B(+12.3%)
Sep 2014
-
$2.42B(+17.9%)
$7.08B(+12.5%)
Jun 2014
-
$2.05B(+111.8%)
$6.29B(+10.8%)
Mar 2014
-
$970.00M(-40.6%)
$5.68B(+1.4%)
Dec 2013
$5.60B(+8.3%)
$1.63B(+0.1%)
$5.60B(+23.0%)
Sep 2013
-
$1.63B(+13.3%)
$4.55B(+1.8%)
Jun 2013
-
$1.44B(+61.7%)
$4.47B(-14.6%)
Mar 2013
-
$891.00M(+51.8%)
$5.23B(+1.2%)
Dec 2012
$5.17B(+13.5%)
$587.00M(-62.1%)
$5.17B(-13.0%)
Sep 2012
-
$1.55B(-29.6%)
$5.94B(+13.4%)
Jun 2012
-
$2.20B(+166.1%)
$5.24B(+17.8%)
Mar 2012
-
$828.00M(-39.1%)
$4.45B(-2.2%)
Dec 2011
$4.55B(-12.6%)
$1.36B(+60.2%)
$4.55B(-9.3%)
Sep 2011
-
$849.00M(-39.9%)
$5.02B(-6.1%)
Jun 2011
-
$1.41B(+51.9%)
$5.34B(+0.5%)
Mar 2011
-
$930.00M(-49.1%)
$5.32B(+2.1%)
Dec 2010
$5.21B(-10.3%)
$1.83B(+55.4%)
$5.21B(+2.9%)
Sep 2010
-
$1.18B(-15.3%)
$5.06B(-11.7%)
Jun 2010
-
$1.39B(+69.4%)
$5.73B(-2.6%)
Mar 2010
-
$819.00M(-51.2%)
$5.88B(+1.3%)
Dec 2009
$5.81B(+9.2%)
$1.68B(-9.0%)
$5.81B(+8.6%)
Sep 2009
-
$1.84B(+19.8%)
$5.35B(+13.0%)
Jun 2009
-
$1.54B(+107.5%)
$4.73B(+1.9%)
Mar 2009
-
$742.00M(-39.1%)
$4.65B(-12.6%)
Dec 2008
$5.32B(+28.6%)
$1.22B(-1.0%)
$5.32B(-1.4%)
Sep 2008
-
$1.23B(-15.3%)
$5.39B(-0.9%)
Jun 2008
-
$1.45B(+3.0%)
$5.44B(+9.4%)
Mar 2008
-
$1.41B(+9.0%)
$4.98B(+20.4%)
Dec 2007
$4.13B
$1.30B(+1.1%)
$4.13B(+11.9%)
Sep 2007
-
$1.28B(+29.8%)
$3.70B(+2.4%)
Jun 2007
-
$988.00M(+73.9%)
$3.61B(-4.5%)
DateAnnualQuarterlyTTM
Mar 2007
-
$568.00M(-33.8%)
$3.78B(-9.4%)
Dec 2006
$4.17B(+3.1%)
$858.00M(-28.3%)
$4.17B(-0.1%)
Sep 2006
-
$1.20B(+3.4%)
$4.18B(-1.1%)
Jun 2006
-
$1.16B(+20.9%)
$4.22B(+3.6%)
Mar 2006
-
$958.00M(+10.9%)
$4.08B(+0.8%)
Dec 2005
$4.04B(+71.3%)
$864.00M(-30.5%)
$4.04B(+1.3%)
Sep 2005
-
$1.24B(+22.8%)
$3.99B(+13.3%)
Jun 2005
-
$1.01B(+9.4%)
$3.53B(+7.7%)
Mar 2005
-
$925.00M(+13.6%)
$3.27B(+38.6%)
Dec 2004
$2.36B(+6.8%)
$814.00M(+5.0%)
$2.36B(+1.8%)
Sep 2004
-
$775.00M(+2.1%)
$2.32B(+28.5%)
Jun 2004
-
$759.00M(+5738.5%)
$1.81B(+5.6%)
Mar 2004
-
$13.00M(-98.3%)
$1.71B(-22.6%)
Dec 2003
$2.21B(+39.0%)
$773.00M(+196.7%)
$2.21B(+10.5%)
Sep 2003
-
$260.50M(-60.8%)
$2.00B(+9.0%)
Jun 2003
-
$663.90M(+29.5%)
$1.83B(+8.1%)
Mar 2003
-
$512.60M(-9.0%)
$1.70B(+6.8%)
Dec 2002
$1.59B(+53.1%)
$563.20M(+494.1%)
$1.59B(+11.9%)
Sep 2002
-
$94.80M(-82.0%)
$1.42B(-5.5%)
Jun 2002
-
$527.10M(+30.2%)
$1.50B(+23.8%)
Mar 2002
-
$404.90M(+2.7%)
$1.21B(+17.0%)
Dec 2001
$1.04B(-13.2%)
$394.20M(+121.8%)
$1.04B(+15.9%)
Sep 2001
-
$177.70M(-25.3%)
$896.20M(-25.1%)
Jun 2001
-
$238.00M(+4.2%)
$1.20B(-2.3%)
Mar 2001
-
$228.50M(-9.3%)
$1.22B(+2.2%)
Dec 2000
$1.20B(+55.2%)
$252.00M(-47.2%)
$1.20B(+14.7%)
Sep 2000
-
$477.30M(+79.6%)
$1.04B(+27.1%)
Jun 2000
-
$265.80M(+31.7%)
$820.60M(-3.3%)
Mar 2000
-
$201.80M(+105.1%)
$848.50M(+10.0%)
Dec 1999
$771.10M(+21.7%)
$98.40M(-61.4%)
$771.10M(-10.8%)
Sep 1999
-
$254.60M(-13.3%)
$864.90M(+11.9%)
Jun 1999
-
$293.70M(+136.1%)
$772.80M(+30.4%)
Mar 1999
-
$124.40M(-35.3%)
$592.70M(-6.5%)
Dec 1998
$633.70M(+23.0%)
$192.20M(+18.3%)
$633.70M(+8.7%)
Sep 1998
-
$162.50M(+43.0%)
$583.00M(+12.3%)
Jun 1998
-
$113.60M(-31.3%)
$519.20M(-5.8%)
Mar 1998
-
$165.40M(+16.9%)
$550.90M(+7.0%)
Dec 1997
$515.10M(-7.3%)
$141.50M(+43.4%)
$515.10M(-6.5%)
Sep 1997
-
$98.70M(-32.1%)
$551.10M(+4.4%)
Jun 1997
-
$145.30M(+12.1%)
$528.00M(-16.8%)
Mar 1997
-
$129.60M(-27.0%)
$634.50M(+14.2%)
Dec 1996
$555.70M(-9.0%)
$177.50M(+134.8%)
$555.70M(+1.5%)
Sep 1996
-
$75.60M(-70.0%)
$547.30M(-10.2%)
Jun 1996
-
$251.80M(+395.7%)
$609.50M(+15.0%)
Mar 1996
-
$50.80M(-70.0%)
$530.00M(-13.2%)
Dec 1995
$610.50M(+52.2%)
$169.10M(+22.7%)
$610.50M(+3.8%)
Sep 1995
-
$137.80M(-20.0%)
$588.40M(+6.4%)
Jun 1995
-
$172.30M(+31.2%)
$552.90M(+22.1%)
Mar 1995
-
$131.30M(-10.7%)
$452.70M(+12.9%)
Dec 1994
$401.10M(+79.8%)
$147.00M(+43.7%)
$401.10M(+0.8%)
Sep 1994
-
$102.30M(+41.9%)
$397.80M(-0.9%)
Jun 1994
-
$72.10M(-9.5%)
$401.30M(+6.8%)
Mar 1994
-
$79.70M(-44.5%)
$375.80M(+68.4%)
Dec 1993
$223.10M(+205.6%)
$143.70M(+35.8%)
$223.10M(+121.8%)
Sep 1993
-
$105.80M(+127.0%)
$100.60M(+1664.9%)
Jun 1993
-
$46.60M(-163.8%)
$5.70M(-141.6%)
Mar 1993
-
-$73.00M(-444.3%)
-$13.70M(-118.8%)
Dec 1992
$73.00M(-28.7%)
$21.20M(+94.5%)
$73.00M(+40.9%)
Sep 1992
-
$10.90M(-59.9%)
$51.80M(+26.7%)
Jun 1992
-
$27.20M(+98.5%)
$40.90M(+198.5%)
Mar 1992
-
$13.70M(-141.1%)
$13.70M(-126.7%)
Dec 1991
$102.40M(-299.2%)
-
-
Mar 1991
-
-$33.30M(-27.0%)
-$51.40M(+715.9%)
Mar 1991
-$51.40M(+102.4%)
-
-
Dec 1990
-
-$45.60M(+744.4%)
-$6.30M(-117.3%)
Sep 1990
-
-$5.40M(-116.4%)
$36.40M(+118.0%)
Jun 1990
-
$32.90M(+178.8%)
$16.70M(-165.7%)
Mar 1990
-$25.40M(-48.3%)
$11.80M(-506.9%)
-$25.40M(-31.7%)
Dec 1989
-
-$2.90M(-88.4%)
-$37.20M(+8.5%)
Sep 1989
-
-$25.10M(+172.8%)
-$34.30M(+272.8%)
Jun 1989
-
-$9.20M
-$9.20M
Mar 1989
-$49.10M
-
-

FAQ

  • What is Amgen annual free cash flow?
  • What is the all time high annual FCF for Amgen?
  • What is Amgen annual FCF year-on-year change?
  • What is Amgen quarterly free cash flow?
  • What is the all time high quarterly FCF for Amgen?
  • What is Amgen quarterly FCF year-on-year change?
  • What is Amgen TTM free cash flow?
  • What is the all time high TTM FCF for Amgen?
  • What is Amgen TTM FCF year-on-year change?

What is Amgen annual free cash flow?

The current annual FCF of AMGN is $10.39B

What is the all time high annual FCF for Amgen?

Amgen all-time high annual free cash flow is $10.56B

What is Amgen annual FCF year-on-year change?

Over the past year, AMGN annual free cash flow has changed by +$3.04B (+41.24%)

What is Amgen quarterly free cash flow?

The current quarterly FCF of AMGN is $4.40B

What is the all time high quarterly FCF for Amgen?

Amgen all-time high quarterly free cash flow is $4.40B

What is Amgen quarterly FCF year-on-year change?

Over the past year, AMGN quarterly free cash flow has changed by +$4.11B (+1422.49%)

What is Amgen TTM free cash flow?

The current TTM FCF of AMGN is $10.39B

What is the all time high TTM FCF for Amgen?

Amgen all-time high TTM free cash flow is $10.87B

What is Amgen TTM FCF year-on-year change?

Over the past year, AMGN TTM free cash flow has changed by +$3.04B (+41.24%)
On this page